Podcast Summary: Becker’s Healthcare Podcast
Guest: Karen Janousek, Chief Population Health and Growth Officer, Sinai Chicago
Date: January 19, 2026
Host: Laura Dyrda (Becker's Healthcare)
Episode Overview
This episode explores the strategic approach to population health at Sinai Chicago, with insights from Karen Janousek on the challenges, successes, and future priorities of leading value-based care in a major safety net health system. Janousek details recent achievements, major headwinds facing the organization, and the fast-evolving landscape of healthcare policy and operations.
Key Discussion Points & Insights
1. Role and Scope at Sinai Chicago
[01:10]
- Karen’s title encompasses managed care, value-based partnerships, ACO (Accountable Care Organization) work, the Physician Hospital Organization, and Illinois Healthcare Transformation Collaboratives.
- Takes on “all other duties as assigned,” adding project-based and cross-disciplinary leadership.
Notable Quote:
"As I like to jokingly say, all other duties as assigned, which includes special projects that come up whether it's within the value based care space or not."
– Karen Janousek [01:41]
2. Key Initiatives and Achievements in the Past Year
[02:13-06:18]
A. Annual Wellness Visits and Value-Based Care
- ACO Reach excellence: Sinai is a star provider for annual wellness visits—critical as a gateway to ongoing care in a high-volume, safety net ER setting.
- The team's frontline community health workers and robust data systems were vital.
- Management focused on daily progress and "all in service of the patient."
Notable Quote:
“Our ER is the front door into our work. And our emphasis on connecting with patients and getting them in for annual wellness visits begins to start creating the connectivity between the patient and the provider.”
– Karen Janousek [02:53]
B. Building a Clinical Drug Trial Program
- Responded to CEO's call for a "service line philosophy" for clinical trials, designing a plan to expand beyond past ad hoc participation.
- Partner selection, EMR (Epic) readiness, and specialty focus were achieved in 2025; implementation expected Q2 2026.
Notable Quote:
“We want to fully expand this [program] where it makes sense ... we know who our first partners will be. Yay.”
– Karen Janousek [05:41]
3. Team Transformation and Performance
[06:38-07:27]
- Describes their approach as “small but mighty,” relying on clear purpose, defined roles, repetition in communication, and fast barrier removal.
- Ongoing update cycles and direct engagement promote focus, despite competing priorities.
Notable Quote:
“It always comes back to communication and explaining...what is the purpose of the project, what is your role in it, what are the goals?”
– Karen Janousek [06:45]
4. Priorities and Headwinds for 2026
[07:34-12:24]
Major Headwinds:
- Federal and state policy impacts: HR1’s effects, shifting Medicaid/ACA eligibility, including eligibility work requirements, pose risk of increased uninsured and higher overall patient morbidity.
- Rising healthcare costs in labor, technology, acquisition, and utilization. Adds volatility to shared savings/value-based contracts.
- Regulatory shifts in Illinois: New 72-hour and Gold Card rules bring opportunities and implementation challenges in payer-provider coordination.
- Persistent workforce shortages and provider burnout threaten performance—particularly for HEDIS measures and shared savings.
Strategic Responses:
- Limiting participation to core quality measures (rather than being “spread too thin” across 19+).
- Standardizing metrics across payers, with progress in Medicaid MCOs.
- Careful selection and implementation of new value-based programs.
Notable Quote:
“How do you balance the near term financial priorities versus the investments that one needs to make in value based care…there’s a push-pull anywhere when doing value based care in this current climate.”
– Karen Janousek [11:40]
5. The Hardest Task Ahead in 2026
[12:52-15:20]
- Work with actuarial teams to analyze missed performance targets in quality and shared savings (“left on the table”), aiming to narrow the gap between potential and realized outcomes.
- Increase focus on strategies to improve performance: reduce length of stay, prevent readmissions, use social media/patient outreach for preventive care uptake.
- Keep providers engaged and energized around value-based care; documentation and care gap closure are “mission critical.”
- Calls out the challenge and uncertainty around new Illinois D-SNP/FIDE-SNP programs.
Notable Quotes:
“One of the hardest things will be to narrow that gap of what the total potential is versus what was actually earned.”
– Karen Janousek [13:12]
“Keeping all the providers engaged in value based care and for them to continue to get excited with value based care...is mission critical.”
– Karen Janousek [14:20]
6. Opportunities for Growth at Sinai Chicago
[16:01-16:55]
- Major growth seen in the scaling of clinical drug trials—brings novel therapeutics to underserved Chicago communities (South and West Sides).
- The “crawl walk run” approach will ensure sustainable, incremental expansion.
- Supports the organization’s mission to bring cutting-edge care equitably to safety net populations.
Notable Quote:
“It’s going to allow us to bring these clinical drug trials...that have not necessarily always been made available to our west and our south side. So very, very excited about that.”
– Karen Janousek [16:34]
Memorable Moments & Quotes
- “Small but mighty team...” (06:39)
- “Our ER is the front door into our work.” (02:53)
- “How do you balance the near term financial priorities versus the investments that one needs to make in value based care…” (11:40)
- “One of the hardest things will be to narrow that gap of what the total potential is versus what was actually earned.” (13:12)
Key Timestamps
- 01:10 – Karen describes her leadership role & responsibilities at Sinai Chicago
- 02:13 – Success in annual wellness visits for ACO Reach population
- 05:00 – Planning and launching a new clinical drug trial program
- 06:38 – Strategies for focusing and transforming teams
- 07:34 – 2026 priorities and headwinds: policy, costs, and regulatory complexity
- 12:52 – Narrowing the gap on missed savings; engaging providers in value-based care
- 16:01 – Growth opportunities: expanding clinical trial access for underserved areas
Conclusion
Karen Janousek offers an honest, systems-level view of the demands and rewards of advancing population health in a large safety net setting. Sinai Chicago’s focus on meaningful patient engagement, operational excellence in value-based care, and targeted innovation paves a strategic path through a rapidly changing and complex landscape.